» Articles » PMID: 12445303

Definitive High Resolution Typing of HLA-E Allelic Polymorphisms: Identifying Potential Errors in Existing Allele Data

Overview
Journal Tissue Antigens
Date 2002 Nov 26
PMID 12445303
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

A set of robust PCR-SSP reactions were developed for each of the five polymorphic sites that define the five alleles of the HLA class Ib gene, HLA-E. This method was developed using 28 homozygous cell lines and further tested in a sample of African-Americans, a sample of Japanese, and a core panel of cell lines compiled for the 13th International Histocompatibility Workshop. Three alleles were found in each of these four sample groups, HLA-E*0101 (64.29, 50.00, 32.00 and 56.58%, respectively), *01031 (5.36, 20.65, 39.00 and 18.42%) and *01032 (30.35, 29.35, 29.00, and 25.00%). HLA-E*0102 was not detected in any of these samples nor in the cell line, LCL 722.221, in which this allele was originally described. HLA-E*0104 was not found either. This latter allele was originally reported in Japanese at a frequency of 1/22 (4.5%), which should have been high enough to have resulted in multiple occurrences of the *0104 allele in the samples tested in this study. We propose that the existence of the HLA-E*0102 and E*0104 alleles should be questioned.

Citing Articles

A monoclonal antibody that recognizes a unique 13-residue epitope in the cytoplasmic tail of HLA-E.

Verhaar E, Gan J, Buhl S, Li Z, Horowitz A, Ploegh H Mol Immunol. 2024; 172:56-67.

PMID: 38901180 PMC: 11257791. DOI: 10.1016/j.molimm.2024.06.004.


A novel and efficient approach to high-throughput production of HLA-E/peptide monomer for T-cell epitope screening.

Vaurs J, Douchin G, Echasserieau K, Oger R, Jouand N, Fortun A Sci Rep. 2021; 11(1):17234.

PMID: 34446788 PMC: 8390762. DOI: 10.1038/s41598-021-96560-9.


HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation.

Duygu B, Olieslagers T, Groeneweg M, Voorter C, Wieten L Front Immunol. 2021; 12:680480.

PMID: 34295330 PMC: 8290519. DOI: 10.3389/fimmu.2021.680480.


Genetic Variants of the NKG2C/HLA-E Receptor-Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma.

Wagner B, Duhrsen U, Huttmann A, Nuckel H, Michita R, Rohn H Cancers (Basel). 2020; 12(11).

PMID: 33218185 PMC: 7699209. DOI: 10.3390/cancers12113429.


Harnessing Unconventional T Cells for Immunotherapy of Tuberculosis.

La Manna M, Orlando V, Tamburini B, Badami G, Dieli F, Caccamo N Front Immunol. 2020; 11:2107.

PMID: 33013888 PMC: 7497315. DOI: 10.3389/fimmu.2020.02107.